A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells

Deoxycytidine analogues (dCas) are widely used for the treatment of malignant diseases. They are commonly inactivated by cytidine deaminase (CDD), or by deoxycytidine monophosphate deaminase (dCMP deaminase). Additional metabolic pathways, such as phosphorylation, can substantially contribute to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ligasová, Anna, Piskláková, Barbora, Friedecký, David, Koberna, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665361/
https://www.ncbi.nlm.nih.gov/pubmed/37993628
http://dx.doi.org/10.1038/s41598-023-47792-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665361/
https://www.ncbi.nlm.nih.gov/pubmed/37993628
http://dx.doi.org/10.1038/s41598-023-47792-4

Ejemplares similares